Disposal

Smith & Nephew Plc 4 May 2001 4 May 2001 SMITH & NEPHEW SELLS ENT TO GYRUS GROUP PLC FOR £65M Smith & Nephew, the global advanced medical devices company, has reached agreement to sell its Ear, Nose & Throat (ENT) business to Gyrus Group plc, a company that designs, develops and markets medical devices for minimally invasive surgery, for a cash consideration of £65m. Completion is subject to approval of the shareholders of Gyrus Group plc and regulatory and other normal clearances. The sale of ENT is expected to be completed in early June 2001, at which time £52.5m of the consideration is payable; the balance being payable in January 2003. Proceeds of the sale of ENT will be used to reduce group borrowings. ENT, which is based in Tennessee, USA, has sales of £30m and employs some 150 people in the development, manufacture and marketing of products for ear, nose and throat surgery. It is the leading player worldwide in otology, providing vent tubes and middle ear implants, and has a significant business in the sinus, rhinology and head & neck sectors. ENT enjoys good relations with leading ENT surgeons worldwide and has pioneered many developments in ENT surgery over the last 40 years. Pre-tax profits in 2000 were £6m on net assets of £14m. Chris O'Donnell, Chief Executive of Smith & Nephew, said: 'ENT is a good business, but does not fit our strategic direction in terms of size and reach. It will be better placed in a company which can help it develop its potential.' 'With the sale of ENT, Smith & Nephew has completed its reshaping from a wide-ranging healthcare business into a highly focused advanced medical devices business concentrated on orthopaedics, endoscopy, advanced wound management and rehabilitation. We are now well placed to take advantage of the higher growth offered by these markets, and grow both organically and by acquisition.' Enquiries: Chris O'Donnell, Chief Executive Tel: +44 (0) 20 7401 7646 Smith & Nephew plc Fax: +44 (0) 20 7930 3426 David Yates Tel: +44 (0) 20 7831 3113 Financial Dynamics Fax: +44 (0) 20 7831 6341
UK 100

Latest directors dealings